Recommended Posts

The best efforts of the scientific community to prove the health benefits of vitamins keep falling short.

This week, researchers reported the disappointing results from a large clinical trial of almost 15,000 male doctors taking vitamins E and C for a decade. The study showed no meaningful effect on cancer rates.

Another recent study found no benefit of vitamins E and C for heart disease.

In October, a major trial studying whether vitamin E and selenium could lower a man's risk for prostate cancer ended amidst worries that the treatments may do more harm than good.

And recently, doctors at Memorial Sloan-Kettering Cancer Center in New York warned that vitamin C seems to protect not just healthy cells but cancer cells, too.

Everyone needs vitamins, which are critical for the body. But for most people, the micronutrients we get from foods usually are adequate to prevent vitamin deficiency, which is rare in the United States. That said, some extra vitamins have proven benefits, such as vitamin B12 supplements for the elderly and folic acid for women of child-bearing age. And calcium and vitamin D in women over 65 appear to protect bone health.

But many people gobble down large doses of vitamins believing that they boost the body's ability to mop up damaging free radicals that lead to cancer and heart disease. In addition to the more recent research, several reports in recent years have challenged the notion that megadoses of vitamins are good for you.

A Johns Hopkins School of Medicine review of 19 vitamin E clinical trials of more than 135,000 people showed high doses of vitamin E (greater than 400 IUs) increased a person's risk for dying during the study period by 4 percent. Taking vitamin E with other vitamins and minerals resulted in a 6 percent higher risk of dying. Another study of daily vitamin E showed vitamin E takers had a 13 percent higher risk for heart failure.

The Journal of Clinical Oncology published a study of 540 patients with head and neck cancer who were being treated with radiation therapy. Vitamin E reduced side effects, but cancer recurrence rates among the vitamin users were higher, although the increase didn't reach statistical significance.

A 1994 Finland study of smokers taking 20 milligrams a day of beta carotene showed an 18 percent higher incidence of lung cancer among beta carotene users. In 1996, a study called Caret looked at beta carotene and vitamin A use among smokers and workers exposed to asbestos, but the study was stopped when the vitamin users showed a 28 percent higher risk for lung cancer and a 26 percent higher risk of dying from heart disease.

A 2002 Harvard study of more than 72,000 nurses showed that those who consumed high levels of vitamin A from foods, multivitamins and supplements had a 48 percent higher risk for hip fractures than nurses who had the lowest intake of vitamin A.

The Cochrane Database of Systematic Reviews looked at vitamin C studies for treating colds. Among more than two dozen studies, there was no overall benefit for preventing colds, although the vitamin was linked with a 50 percent reduction in colds among people who engaged in extreme activities, such as marathon runners, skiers and soldiers, who were exposed to significant cold or physical stress. The data also suggested vitamin C use was linked with less severe and slightly shorter colds.

In October 2004, Copenhagen researchers reviewed seven randomized trials of beta carotene, selenium and vitamins A, C and E (alone or in combination) in colon, esophageal, gastric, pancreatic and liver cancer. The antioxidant users had a 6 percent higher death rate than placebo users.

Two studies presented to the American College of Cardiology in 2006 showed that vitamin B doesn't prevent heart attacks, leading The New England Journal of Medicine to say that the consistency of the results "leads to the unequivocal conclusion" that the vitamins don't help patients with established vascular disease.

The British Medical Journal looked at multivitamin use among elderly people for a year but found no difference in infection rates or visits to doctors.

Despite a lack of evidence that vitamins actually work, consumers appear largely unwilling to give them up. Many readers of the Well blog say the problem is not the vitamin but poorly designed studies that use the wrong type of vitamin, setting the vitamin up to fail. Industry groups such as the Council for Responsible Nutrition also say the research isn't well designed to detect benefits in healthy vitamin users.

source

  • 2 weeks later...
This topic is now closed to further replies.
  • Recently Browsing   0 members

    • No registered users viewing this page.
  • Posts

    • Salesforce to acquire Fin, formerly Intercom, for over $3 billion by David Uzondu Image via DepositPhotos.com Salesforce today announced that it has reached an agreement with customer support software company Fin to buy the company for around $3.6 billion. Salesforce expects the transaction to close in the fourth quarter of its fiscal year 2027, and the acquisition will not change its financial guidance previously announced on May 27. Marc Benioff, CEO of Salesforce, in its press release, claimed that acquiring the startup gives Salesforce an immediate AI agent that resolves support tickets across email, WhatsApp, SMS, and Slack: You might know Fin by its former name, Intercom. If you have ever been on a website or inside a mobile app and noticed a little chat bubble widget floating in the bottom right corner of your screen, often featuring a friendly face and a message like, "Hi! How can we help you today?" you were almost certainly looking at Intercom. Intercom became Fin just last month, transforming itself into an "AI-first" platform that handles customer issues with little need for humans to intervene. The new name originates from the company's highly successful AI customer service agent, which it launched way back in 2023. This digital assistant supposedly resolves about 76% of customer service volume end-to-end on its own, so the business rebranded to match its primary software tool. Fin's new owners, Salesforce, went on an acquisition spree over the last few years, and some of them you might recognize, like its 2020 $27.7 Billion acquisition of Slack. The last few months saw the enterprise giant buy several startups, including m3ter, Momentum, Cimulate, and Contentful. Salesforce said that when the Fin deal pulls through, customers will "deploy AI agents across" various service operations, which will complement Agentforce, the platform that enables businesses to deploy customizable autonomous digital workers.
    • Microsoft now allows you to tweak Visual Studio to new extremes by Usama Jawad Visual Studio 2026 recently netted a powerful feature that finally allows developers to review Git Pull Requests (PRs) directly in the integrated development environment (IDE), without needing to switch to the browser. However, that's not all that Microsoft introduced in the latest version, as it also offered a useful way to customize the IDE to their heart's content. Although Visual Studio 2026 already provides lots of stock themes based on Fluent Design principles, Microsoft understands that people still want to customize them further according to their preferences. The IDE now offers a new configuration page for themes under Tools > Options > Environment > Visual Experience > Theme colors. This allows you to set hex color codes for accent colors, hover states, and more, and apply them without requiring a restart. The Redmond tech giant further says that: Microsoft is also offering granular color tokens that allow you to customize various UX elements like the tab header without impacting the rest of the shell chrome. Your themes are also stored in JSON format in %LOCALAPPDATA%\Microsoft\VisualStudio\18.0_xxxxxxxx\ColorThemes, which basically enables you to share it with others or override existing themes. This is a major improvement in terms of the user experience powering these customization capabilities. This is because extensions were required to replace the theme, and it was not very easy to make minor adjustments. This theme configuration UX solves this problem and is available in Visual Studio 2026 version 18.7, available here.
  • Recent Achievements

    • Week One Done
      Jeroen Wilms earned a badge
      Week One Done
    • Week One Done
      rolfus earned a badge
      Week One Done
    • One Month Later
      Leroy Jethro Gibbs earned a badge
      One Month Later
    • Conversation Starter
      flexorcist earned a badge
      Conversation Starter
    • One Month Later
      AndreaB earned a badge
      One Month Later
  • Popular Contributors

    1. 1
      +primortal
      503
    2. 2
      +Edouard
      201
    3. 3
      PsYcHoKiLLa
      127
    4. 4
      Steven P.
      82
    5. 5
      ATLien_0
      76
  • Tell a friend

    Love Neowin? Tell a friend!